STATE OF FLORIDA

DEPARTMENT OF CORRECTIONS REQUEST FOR INFORMATION (RFI) #DC-RFI-14-072 CONDUCTING DRUG TESTING OF OFFENDERS ON COMMUNITY SUPERVISION FOR ESCAMBIA COUNTY January 20, 2015 I.

INTRODUCTION/STATEMENT OF NEED The Florida Department of Corrections, herein referred to as “Department”, is seeking information from experienced, qualified vendors who can provide laboratory drug testing collections site(s) and laboratory drug testing services to determine the presence of alcohol and/or controlled substances, which includes the Immunoassay Test and Gas Chromatography/Mass Spectrometry (GC/MS) for offenders on supervision with the Department. Services shall include the provision of all necessary supplies, transportation and handling of specimens, confirmation testing and reporting of test results. The Department is requesting responses from vendors who have a minimum of three (3) years of business/corporate experience within the last five (5) years administering/managing drug testing services to a population of offenders in the Department’s Pensacola office location in Escambia County. Probation and Parole Office Location Sites for Escambia County 015 - Pensacola West 3101 North Davis Highway Pensacola, Florida 32503 Telephone: (850) 595-8845 Fax: (850) 595-8860 016 – Pensacola North 3101 North Davis Highway Pensacola, Florida 32503 Telephone: (850) 595-8845 Fax: (850) 595-8860 018 - Pensacola Central 3101 North Davis Highway Pensacola, Florida 32503 Telephone: (850) 595-8845 Fax: (850) 595-8860 Page 4 of 4

DC-RFI-14- 072

II.

BACKGROUND Pursuant to Chapter 945, Florida Statutes (F.S.), the Department is responsible for the supervisory and protective care, custody, and control of its inmate population and supervision of its probationer population. The Department desires to detect and deter illegal drug use by offenders that are on community supervision with Florida Department of Corrections. The Department has approximately 3,000 offenders on community supervision in Escambia County. A resource for offenders to obtain laboratory drug testing services is needed within the geographical area. In the fiscal year of 2013-2014, the Pensacola Probation and Parole Offices in Escambia County collected approximately 7,670 specimens. Of these specimens (7,670), approximately 739 GC/MS confirmations were conducted with an average of two (2) drugs per confirmation.

III.

PURPOSE OF RFI Pursuant to Rule 60A-1.042, Florida Administrative Code (F.A.C.), an agency may request information from the business community by issuing a written Request for Information (RFI). Agencies may use RFI’s in circumstances including, but not limited to, determining whether or not to competitively procure a commodity or contractual service, determining what solicitation process to use for a particular need, or researching general, special, and/or technical specifications for a solicitation. A vendor’s answer to a RFI is not an offer and shall not be used to justify a contract with that vendor without otherwise complying with Chapter 287, F.S., and Rule 60A-1, F.A.C. Vendors submitting answers to an agency’s RFI are not prohibited from responding to any related subsequent solicitation. The Department reserves the right to use or reject any information supplied in response to this RFI. Interested parties are requested to answer all questions contained in Section IV of this RFI. Additionally, interested parties shall provide details of enhancements and other applications and systems that may apply to the delivery of services or technology described.

IV.

QUESTIONS AND RESPONSES Responses to this RFI should indicate how a vendor would provide laboratory drug testing, including but not limited to necessary supplies, transportation of specimens, handling of specimens, confirmation testing and reporting of test results. In addition, responses should include narrative and documents addressing the following specific statements and questions: 1.

Does your company maintain all necessary certifications, license as required by the State of Florida to conduct laboratory drug testing?

2.

Has your laboratory State of Florida certification, license been suspended for any reason? If so, what were the reason(s)?

3.

Is your laboratory certified by the Substance Abuse Mental Health Services Administration (SAMHSA)? Page 4 of 4

DC-RFI-14- 072

4.

Has your laboratory SAMHSA certification been suspended for any reason? If so, what were the reason(s)?

5.

Does your laboratory provide confirmation testing using Gas Chromatography/Mass Spectrometry?

6.

Does your laboratory provide specimen validity testing (defined as diluted, adulterated, and/or substituted as recommended by the Substance Abuse Mental Health Services Administration)?

7.

Describe your company’s experience in specimen collection and conducting drug testing? The response should also include assigned staff’s experience.

8.

Describe how your company will ensure adequate staff is available during normal working hours (8:00 a.m. – 5:00 p.m. Eastern Time) at the Laboratory’s collection site(s) to collect specimens and conduct laboratory testing and confirmations daily.

9.

The Department’s protocol requires same gender observation when collecting specimens from offenders. Does your company have adequate staff to ensure that all specimens collected are observed during the collection process by the same gender?

10.

Does your company have the capability to setup accounts and subaccounts to provide electronic invoicing under one contract if necessary?

11.

Does your company utilize the thresholds listed below that will meet the following cut off levels? Drug Name

Initial Test

Confirmation

Cocaine (cocaine and metabolites)

300 ng/ml

150 ng/ml

Opiates (Codeine, Morphine, Hydrocodone, Hydromorphone, Oxycodone, Oxymorphone)

300 ng/ml

150 ng/ml

NA

10 ng/ml

PCP (Phencyclidine)

25 ng/ml

25 ng/ml

Amphetamines (Amphetamine, Methamphetamine)

1000 ng/ml

500 ng/ml

−

6-Acetymorphine (6-AM) Heroin metabolite

−

Amphetamine

1000 ng/ml

500 ng/ml

−

Methamphetamine

1000 ng/ml

500 ng/ml

−

MDMA ( MDMA, MDA, MDEA)

500 ng/ml

250 ng/ml

50 ng/ml

15 ng/ml

Cannabis (Cannabinoids, THC)

Page 4 of 4

DC-RFI-14- 072

Drug Name Benzodiazepines (Oxazepam, Temazepam, alpha-Hydroxyalprazolam, Lorazepam, Nordiazepam)

Initial Test

Confirmation

200 or 300 ng/ml

150 ng/ml

200 or 300 ng/ml

150 ng/ml

Alcohol

.02% g/dl

.02% g/dl

Methadone

300 ng/ml

150 ng/ml

Lyseric Acid Diethylamide (LSD)